DUBLIN, 23 Aug 2021 / PRNewswire / – The report “Global Gynecology Drugs Market, By Therapeutics (Hormonal Therapy vs. Non-hormonal Therapy), By Indication, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2026” has been added to ResearchAndMarkets.com offer.

Research and Markets logo

The global gynecological drugs market has been valued at $ 13,343.23 million in 2020 and is expected to grow at a CAGR of 7.42% over the forecast years, 2022-2026, due to the rapid increase in cases of gynecologic cancer and other gynecologic disorders.

These diseases have increased the death rate of the female population over the past five years. Thus, the government is now working to sensitize and alert the female population to monitor their personal well-being and their gynecological health problems. These deductions should justify the growth of the market over the forecast years.

Moreover, lifestyle changes among women are also expected to drive the market growth. With increasing number of working women and their jobs in various industries, the risks of infection and diseases due to prolonged exposure to harmful chemicals and toxins are said to positively influence the growth of the global gynecological drugs market.

Gynecological drugs are therapeutic and biological products which are administered for the treatment of the patient’s gynecological disorders and conditions. Gynecological disorders affect the reproductive system of females and cause infection or functional failure in parts such as uterus, bladder, urethra, ovaries, appendages, etc.

Recent developments in gynecological therapeutics and technologically advanced devices for the early diagnosis of gynecological disorders are expected to drive the market growth over the next five years.

The global gynecological drugs market is segmented on the basis of therapeutics, indication, distribution channel, regional distribution, and competitive landscape. Based on therapeutics, the market is further divided into hormone therapy and non-hormonal therapy. In addition, rapid progress in new product development supports market growth over the next five years.

Hormone therapy is also expected to hold a large share of the market due to the increasing demand for new, state-of-the-art drugs, although the therapy has some side effects such as the risk of breast cancer. On the basis of distribution channel, the market is divided into hospital pharmacies, retail pharmacies, and online pharmacies. The online pharmacy segment is expected to dominate the market during the forecast period, 2022-2026.

Market players are actively involved in technological advances in therapy as well as in research and development of medical devices used for the administration of gynecological drugs.

The large companies in the market are

  • Amgen Inc.

  • F. Hoffmann-La Roche Ltée.

  • Novartis Ltd.

  • Bayer AG

  • Merck & Co., Inc.

  • GlaxoSmithKline Plc

  • Sanofi SA

  • Eli Lilly and Company Ltd.

  • Ferring Pharmaceuticals A / S

  • AstraZeneca Plc

  • TherapeuticsMD, Inc.

  • AbbVie Inc.

  • Abbott Laboratories Ltd.

  • Lupine Pharmaceuticals, Inc.

  • Pfizer Inc.

Key target audience:

  • Manufacturers, end users and other stakeholders

  • Gynecology distributors and suppliers and other stakeholders

  • Organizations, forums and alliances related to gynecological medicines

  • Market studies and consulting firms

Scope of the report:

Years considered for this report:

Global Gynecology Drugs Market, By Therapeutics:

  • Hormonal therapy

  • Non-hormonal therapy

Global Gynecological Drugs Market, By Indication:

Global Gynecology Drugs Market, By Distribution Channel:

  • Hospital pharmacies

  • Retail pharmacies

  • Online pharmacies

Global Gynecology Drugs Market, By Region:

  • North America

  • United States

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • South America

  • Brazil

  • Argentina

  • Colombia

  • Middle East & Africa

  • South Africa

  • Saudi Arabia

  • United Arab Emirates

For more information on this report, visit https://www.researchandmarkets.com/r/fqf2lx

Media contact:

Research and markets
Laura Wood, senior
[email protected]

For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1904
Fax (outside the United States): + 353-1-481-1716



View original content: https://www.prnewswire.com/news-releases/global-gynecology-drugs-market-report-2021-2026-focus-on-cancers-polycystic-ovary-syndrome-contraception-endometriosis-female – infertility-infections-post-menopausal-disorders-301360513.html

SOURCE Research and Markets